Assembly Biosciences, Inc. (ASMB) Misses Q3 EPS by 3c

Assembly Biosciences, Inc. (NASDAQ: ASMB) reported Q3 EPS of ($0.27), $0.03 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Assembly Biosciences, Inc. (ASMB) click here.

You May Also Be Interested In

• Assembly Biosciences (ASMB) Tops Q2 EPS by 53c
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c